Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 11
Submit an article Journal homepage
1,202
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma

Paula Rodríguez Oteroa Clínica Universidad de Navarra, Pamplona, SpainCorrespondence[email protected]
View further author information
,
Kevin Towleb Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, CanadaView further author information
,
Shannon Copeb Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, CanadaView further author information
,
Clyde Caisipb Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, CanadaView further author information
,
Faith E. Daviesc Perlmutter Cancer Center, NYU Langone Health, New York, NY, USAView further author information
,
Michel Delforged Department of Haematology, University Hospital Leuven, Leuven, BelgiumView further author information
,
Katja Weisele Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center of Hamburg-Eppendorf, Hamburg, GermanyView further author information
,
Thomas S. Marshallf Bristol Myers Squibb, Princeton, NJ, USAView further author information
,
Korinna Karampampag Bristol Myers Squibb, Uxbridge, UKView further author information
,
Dieter Ayersb Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, CanadaView further author information
,
Ali Mojebib Evidence Synthesis & Decision Modeling, PRECISIONheor, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0003-2318-8627View further author information
ORCID Icon,
Julia Bravermanf Bristol Myers Squibb, Princeton, NJ, USAView further author information
,
James Farrellh Bristol Myers Squibb, Dublin, IrelandView further author information
&
Devender Dhandaf Bristol Myers Squibb, Princeton, NJ, USAView further author information
 show all
Pages 1864-1869 | Received 17 Feb 2023, Accepted 05 Jul 2023, Published online: 27 Jul 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.